31 Aug 2023 15:51
Â
31 August 2023
Â
Â
BEXIMCO PHARMACEUTICALS LIMITED
Â
Re-appointment of Independent Director
Â
Beximco Pharmaceuticals Limited ("Beximco Pharma", "BPL" or "the Company"; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announced that, it has re-appointed Professor Mamtaz Uddin Ahmed as an Independent Non-Executive Director for the second consecutive term with immediate effect. Professor Mamtaz Uddin Ahmed has successfully completed his first three-year term that ended on 29 July 2023.
Â
Â
For further information, please visit www.beximcopharma.com or enquire to:
Â
Beximco Pharma
Â
Nazmul Hassan MP, Managing Director
Tel: +880 2 58611001, Ext.20080
Â
Mohammad Asad Ullah FCS
Executive Director & Company Secretary
Tel: 880 2 58611001, Ext. 10140
Â
Mohammad Ali Nawaz, Chief Financial Officer
Tel: +880 2 58611001, Ext.20030
Â
SPARK Advisory Partners Limited (Nominated Adviser)
Mark Brady / Andrew Emmott
Tel: +44 (0) 20 3368 3551 / 3555
Â
SP Angel Corporate Finance LLP (Broker)
Vadim Alexandre / Abigail Wayne
Tel: +44 (0) 20 3470 0470
Â
FTI Consulting
Simon Conway / Victoria Foster Mitchell
Tel: +44 (0) 20 3727 1000
Â
Notes to Editors
Â
About Beximco Pharmaceuticals Limited
Â
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Since its inception in 1976, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines. Company's broad portfolio of generics encompasses diverse delivery systems such as tablets, capsules, liquids, semi-solids, intravenous fluids, metered dose inhalers, dry powder inhalers, sterile ophthalmic drops, insulins, prefilled syringes, injectables, nebuliser solutions, oral soluble films etc. The Company also undertakes contract manufacturing for multinational and leading global generic pharmaceutical companies.
Â
Beximco Pharma′s state-of-the-art manufacturing facilities are certified by global regulatory authorities of USA, Europe, Australia, Canada, GCC and Latin America, among others and it has a geographic footprint in more than 50 countries. More than 5500 employees are driving the company towards achieving its aspiration to be among the most admired companies in the world.
Â